D
Douglas B. Kell
Researcher at University of Liverpool
Publications - 657
Citations - 55792
Douglas B. Kell is an academic researcher from University of Liverpool. The author has contributed to research in topics: Systems biology & Dielectric. The author has an hindex of 111, co-authored 634 publications receiving 50335 citations. Previous affiliations of Douglas B. Kell include Max Planck Society & University of Wales.
Papers
More filters
Journal ArticleDOI
If you've got it, flaunt it — rapid screening for microbial biocatalysts
Posted ContentDOI
VAE-Sim: a novel molecular similarity measure based on a variational autoencoder
TL;DR: The VAE vector distances provide a rapid and novel metric for molecular similarity that is both easily and rapidly calculated.
Posted ContentDOI
Why most transporter mutations that cause antibiotic resistance are to efflux pumps rather than to import transporters
Pedro Mendes,Enrico Girardi,Giulio Superti-Furga,Giulio Superti-Furga,Douglas B. Kell,Douglas B. Kell +5 more
TL;DR: In this article, the authors analyse quantitatively a mathematical model consisting of one generic equilibrative transporter and one generic concentrative uptake transporter (representing any number of each), together with one generic efflux transporter.
Journal ArticleDOI
Going places: forced and natural molecular evolution
TL;DR: In a recent workshop sponsored by the UK Biotechnolog9and Biological Sciences Research Council, a variety of speakers demonstrated how our knowledge of natural evolutionary processes, and our ability to manipulate nucleotide sequences both in vitro and in vivo, lead, in some instances, to the development of greatly improved cells and enzymes capable of displaying highly desirable and novel metabolic activities, as well as to novel and potent analytical methods as discussed by the authors.
Journal ArticleDOI
Electromicrobial transformations using the pyruvate synthase system of Clostridium sporogenes
TL;DR: This method was used for a detailed study of the enyzmology of the overall reaction catalysed by pyruvate synthase in Clostridium sporogenes and could be utilised to harness such reductive carboxylations for commercial biotransformations of xenobiotics.